The role of TDP-43 and co-regulation of TDP-43 and Coilin and/or CBs warrants further investigation in terms of cancer drug responses especially since TDP-43 levels decrease in advanced prostate cancer [11] and this may affect the nuclear responses of prostate cancer cells to cytotoxic drugs. This evidence concerns the gene CBS and prostate carcinoma.